John W. Verbicky
Corporate Officer/Principal bij American Chemical Society
Actieve functies van John W. Verbicky
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
The Society of Plastics Engineers
The Society of Plastics Engineers Internet Software/ServicesTechnology Services The Society of Plastics Engineers is a global organization with over 22,500 members in 84 countries. The non-profit company is based in Danbury, CT and has subsidiaries in France. The company's mission is to unite plastics professionals worldwide and help them succeed by providing networking opportunities, events, training, and knowledge sharing. The CEO of the company is Patrick Farrey. | Corporate Officer/Principal | - | - |
Loopbaan van John W. Verbicky
Eerdere bekende functies van John W. Verbicky
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Envirokare Tech, Inc.
Envirokare Tech, Inc. Miscellaneous ManufacturingProducer Manufacturing Envirokare Tech, Inc. designs, develops and manufactures, utilizes proprietary thermoplastic composite technologies, including Thermo Plastic Flowforming for TPF(TM). The end-use products of this process are fabricated using other materials, including wood, metal, concrete or reinforced thermoset resins-fiber-glass. The Group also focuses licenses proprietary process technology to manufacturers and converters. The company was incorporated on June 15, 1998 and is headquartered in New York, NY. | Directeur/Bestuurslid | - | 05-12-2008 |
GE AEROSPACE | Corporate Officer/Principal | - | - |
Chemfab Corp.
Chemfab Corp. TextilesProcess Industries Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low. | President | - | - |
LRM Industries International, Inc.
LRM Industries International, Inc. Miscellaneous ManufacturingProducer Manufacturing LRM Industries International, Inc. manufactures fiber-reinforced structural thermoplastic parts. The company is headquartered in West Melbourne, FL. | Algemeen Directeur | 01-03-2005 | - |
President | 01-03-2005 | - |
Opleiding van John W. Verbicky
Georgia Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Corporate Officer/Principal | 3 |
President | 2 |
Director/Board Member | 1 |
Sectoraal
Producer Manufacturing | 4 |
Commercial Services | 2 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GE AEROSPACE | Producer Manufacturing |
Bedrijven in privébezit | 5 |
---|---|
Envirokare Tech, Inc.
Envirokare Tech, Inc. Miscellaneous ManufacturingProducer Manufacturing Envirokare Tech, Inc. designs, develops and manufactures, utilizes proprietary thermoplastic composite technologies, including Thermo Plastic Flowforming for TPF(TM). The end-use products of this process are fabricated using other materials, including wood, metal, concrete or reinforced thermoset resins-fiber-glass. The Group also focuses licenses proprietary process technology to manufacturers and converters. The company was incorporated on June 15, 1998 and is headquartered in New York, NY. | Producer Manufacturing |
LRM Industries International, Inc.
LRM Industries International, Inc. Miscellaneous ManufacturingProducer Manufacturing LRM Industries International, Inc. manufactures fiber-reinforced structural thermoplastic parts. The company is headquartered in West Melbourne, FL. | Producer Manufacturing |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
The Society of Plastics Engineers
The Society of Plastics Engineers Internet Software/ServicesTechnology Services The Society of Plastics Engineers is a global organization with over 22,500 members in 84 countries. The non-profit company is based in Danbury, CT and has subsidiaries in France. The company's mission is to unite plastics professionals worldwide and help them succeed by providing networking opportunities, events, training, and knowledge sharing. The CEO of the company is Patrick Farrey. | Technology Services |
Chemfab Corp.
Chemfab Corp. TextilesProcess Industries Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low. | Process Industries |
- Beurs
- Insiders
- John W. Verbicky
- Ervaring